MY142063A - Ppar activating compound and pharmaceutical composition containing the compound - Google Patents

Ppar activating compound and pharmaceutical composition containing the compound

Info

Publication number
MY142063A
MY142063A MYPI20043550A MY142063A MY 142063 A MY142063 A MY 142063A MY PI20043550 A MYPI20043550 A MY PI20043550A MY 142063 A MY142063 A MY 142063A
Authority
MY
Malaysia
Prior art keywords
group
compound
atom
hydrogen atom
pharmaceutical composition
Prior art date
Application number
Other languages
English (en)
Inventor
Yukiyoshi Yamazaki
Tsutomu Toma
Masahiro Nishikawa
Hidefumi Ozawa
Ayumu Okuda
Takaaki Araki
Kazutoyo Abe
Soichi Oda
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of MY142063A publication Critical patent/MY142063A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MYPI20043550 2003-09-03 2004-09-01 Ppar activating compound and pharmaceutical composition containing the compound MY142063A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49935703P 2003-09-03 2003-09-03
JP2003317353 2003-09-09
JP2003364817 2003-10-24

Publications (1)

Publication Number Publication Date
MY142063A true MY142063A (en) 2010-08-30

Family

ID=43426133

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20043550 MY142063A (en) 2003-09-03 2004-09-01 Ppar activating compound and pharmaceutical composition containing the compound

Country Status (6)

Country Link
AT (1) ATE494281T1 (da)
DE (1) DE602004030921D1 (da)
DK (1) DK1661890T3 (da)
MY (1) MY142063A (da)
PT (1) PT1661890E (da)
SI (1) SI1661890T1 (da)

Also Published As

Publication number Publication date
ATE494281T1 (de) 2011-01-15
PT1661890E (pt) 2011-04-04
DE602004030921D1 (de) 2011-02-17
DK1661890T3 (da) 2011-03-14
SI1661890T1 (sl) 2011-04-29

Similar Documents

Publication Publication Date Title
EA200600527A1 (ru) Активирующее ppar соединение и содержащая его фармацевтическая композиция
AR058403A1 (es) PIRIMIDINILOXI Y PIRIDINILOXI UREAS SUSTITUíDAS COMO INHIBIDORES DE PROTEíNA QUINASAS, COMPOSICIONES FARMACÉUTICAS QUE LAS CONTIENEN Y SU USO EN LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR LA ACTIVIDAD BASAL DE B-RAF.
WO2004010949A3 (en) Compounds active in spinigosine 1-phosphate signaling
HRP20000406B1 (en) Arylpiperazines having activity at the serotonin 1a receptor
WO2004000820A3 (en) Certain aromatic monocycles as kinase modulators
DK0769010T3 (da) 2-[1',2',4'-triazol-3'-yloxymethylen]-anilider og deres anvendelse som pesticider
TW200505874A (en) New compounds with therapeutic effect
NO20070468L (no) Sammensetninger og fremgangsmater for behandling av dyslipidemi
HRP20080113T3 (hr) Supstituirani piridinilni i pirimidinilni derivati kao modulatori metabolizma i liječenje bolesti koje su s tim povezane
BG108089A (en) Pyridine matrix metalloproteinase inhibitors
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
WO2007071632A3 (en) 2-pyridin-2-yl-quinazoline derivatives as potassium channel modulating agents for the treatment of respiratory diseases
AR083020A1 (es) Uso de un compuesto de [3-(1-(1h-imidazol-4-il)etil)-2-metilfenil]metanol para preparar un medicamento util para tratar enfermedades y afecciones de la piel, articulo de fabricacion y composicion farmaceutica que lo comprenden
TW200745034A (en) New compounds
PH12013502359A1 (en) Carboxamide compounds and their use as calpain inhibitors
WO2004110344A3 (en) New azetidine compounds
CO5640099A2 (es) Derivados de oxifenilo aromaticos y de sulfanilfenilo aromaticos
MXPA05013652A (es) Modulador del receptor canabinoide.
AR053554A1 (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
AR052898A1 (es) Derivados de la n-[(4,5-difenil -2-tienil) metil] amina, su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para enfermedades mediadas por los receptores canabinoides cb1
MY142063A (en) Ppar activating compound and pharmaceutical composition containing the compound
GEP20115222B (en) New pharmaceutical compounds
TW200634001A (en) Novel compounds
NZ595113A (en) Rosuvastatin and atorvastatin derivatives
EA201000084A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их